针对非创伤性非髋部骨折门诊患者的人群骨质疏松干预的经济学评价:「Catch a Break」1i [C 型] FLS
在加拿大阿尔伯塔省实施针对非髋部骨折老年门诊患者的人群骨折联络服务(FLS)「Catch a Break」,每例成本 44 加元,较常规护理增加双膦酸盐治疗率 4.3% 至 17.5%(p < 0.001),每获得 1 个质量调整生命年(QALY)的增量成本为 9200 加元。若排除「其他」骨折并将干预成本降低 25%,该服务可转为成本节省。
要点
- 每 10000 例入组患者一生中可避免 4 例髋部骨折(共 14 例骨折)并获得 12 个 QALY。
- 在 10000 次概率模拟中,85% 的模拟显示 CaB 具有成本效益。
- 排除「其他」骨折且干预成本降低 25% 时,CaB 转为成本节省。
核心结论
- 在阿尔伯塔省实施的一种相对低成本的人群 1i(=C 型)FLS 具有很好的成本效益。
- 若 CaB 排除「其他」骨折并将干预成本降低 25%,则可转为成本节省,任何更有效且更廉价的 FLS 也会如此。
研究设计与样本
- 研究为对「Catch a Break」FLS 的经济学分析,该 FLS 位于加拿大阿尔伯塔省,以人群为基础,通过病例发现识别非创伤性上肢、脊柱、骨盆或「其他」非髋部骨折的老年门诊患者,并提供电话外展和向患者及其医生发放印刷教育材料。
- 成本效果通过马尔可夫决策分析模型评估,成本以 2014 年加拿大元表示,效果基于复发骨折和质量调整生命年(QALY)的模型模拟。
- 视角为医疗付费方,时间范围为终生,成本和收益按 3% 贴现。
主要发现
- 1 年内 CaB 入组 7323 例门诊患者(平均年龄 67 岁,75% 女性,69% 上肢骨折),平均每例成本 44 加元。
- 与常规护理相比,CaB 使双膦酸盐治疗率增加 4.3% 至 17.5%(p < 0.001)。
- 在患者一生中,每 10000 例入组 CaB 的患者可避免 4 例髋部骨折(共 14 例骨折)并获得 12 个 QALY。
- 与常规护理相比,CaB 的增量成本效果估计为每 QALY 9200 加元。
- 在 10000 次概率模拟中,85% 的模拟显示 CaB 具有成本效益。
关键数值与推荐
- 敏感性分析显示,若排除「其他」骨折并将干预成本降低 25%,CaB 将转为成本节省。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Fracture liaison services (FLS) are advocated to improve osteoporosis treatment after fragility fracture, but there are few economic analyses of different models. A population-based 1i [=type C] FLS for non-hip fractures was implemented and it costs $44 per patient and it was very cost-effective ($9200 per QALY gained). Small operational changes would convert it from cost-effective to cost-saving. INTRODUCTION: After fragility fracture, <20% of patients receive osteoporosis treatment. FLS are recommended to address this deficit but there are very few economic analyses of different FLS models. Therefore, we conducted an economic analysis of a 1i (=type C) FLS called "Catch a Break (CaB)." METHODS: CaB is a population-based FLS in Alberta, Canada, that case-finds older outpatients with non-traumatic upper extremity, spine, pelvis, or "other" non-hip fractures and provides telephonic outreach and printed educational materials to patients and their physicians. Cost-effectiveness was assessed using Markov decision-analytic models. Costs were expressed in 2014 Canadian dollars and effectiveness based on model simulations of recurrent fractures and quality-adjusted life years (QALYs). Perspective was healthcare payer; horizon was lifetime; and costs and benefits were discounted 3%. RESULTS: Over 1 year, CaB enrolled 7323 outpatients (mean age 67 years, 75% female, 69% upper extremity) at average cost of $44 per patient. Compared with usual care, CaB increased rates of bisphosphonate treatment by 4.3 to 17.5% (p < 0.001). Over their lifetime, for every 10,000 patients enrolled in CaB, 4 hip fractures (14 fractures total) would be avoided and 12 QALYs gained. Compared with usual care, incremental cost-effectiveness of CaB was estimated at $9200 per QALY. CaB was cost-effective in 85% of 10,000 probabilistic simulations. Sensitivity analyses showed if "other" fractures were excluded and intervention costs reduced 25% that CaB would become cost-saving. CONCLUSIONS: A relatively inexpensive population-based 1i (=type C) FLS was implemented in Alberta and it was very cost-effective. If CaB excluded "other" fractures and decreased intervention costs by 25%, it would be cost-saving, as would any FLS that was more effective and less expensive.
引用
- Majumdar SR, Lier DA, Hanley DA, et al. Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS. Osteoporos Int. 2017. PMID: 28275838. doi:10.1007/s00198-017-3986-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。